Correlation Between Acumen Pharmaceuticals and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Acrivon Therapeutics,.
Diversification Opportunities for Acumen Pharmaceuticals and Acrivon Therapeutics,
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acumen and Acrivon is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Acrivon Therapeutics,
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 1.32 times more return on investment than Acrivon Therapeutics,. However, Acumen Pharmaceuticals is 1.32 times more volatile than Acrivon Therapeutics, Common. It trades about -0.09 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about -0.19 per unit of risk. If you would invest 274.00 in Acumen Pharmaceuticals on August 25, 2024 and sell it today you would lose (37.00) from holding Acumen Pharmaceuticals or give up 13.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Acrivon Therapeutics, |
Acumen Pharmaceuticals and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Acrivon Therapeutics,
The main advantage of trading using opposite Acumen Pharmaceuticals and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Acumen Pharmaceuticals vs. Eliem Therapeutics | Acumen Pharmaceuticals vs. HCW Biologics | Acumen Pharmaceuticals vs. Scpharmaceuticals | Acumen Pharmaceuticals vs. Milestone Pharmaceuticals |
| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |